Flies can be trained to associate an odor with the presence of an electric shock in a training apparatus called the T-maze. The resulting olfactory memories can be stored and accessed for several days.
Published on 29/03/2022
What is memory?
There is still no clear answer to this fundamental question. But the research team at the Friedrich Miescher Institute, or FMI, in Basel has been instrumental in advancing what we know about how the brain works – and in particular memory. Their biggest contribution – and what earned them worldwide recognition – has been their trailblazing approach to study the brain in terms of neuronal circuits.
“One of the biggest challenges in neuroscience – and for neurological and psychiatric treatments – is that we still lack a complete mechanistic understanding of the neuronal circuitry of the human brain,” says Andreas Luethi, senior group leader and a specialist in the circuitry of learning and memory. “During the last 20 years, neuroscience has witnessed enormous progress in understanding how neuronal circuits program memories, movement and behavior, and the FMI has really been at the center of this development.”
The billions of neurons that form the brain have different roles and they interact in groups of tens, thousands, or even larger ensembles. These interactions form the circuitry of the brain – computing all of our senses, actions and memories. The FMI’s neurobiology group was one of the first to focus on this ambitious approach and they have spent the last 20 years deciphering this hidden “language” of the brain.
While such research is far away from the clinic, their findings lay the foundation for future treatments for neurodegenerative diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS) as well as psychiatric disorders including anxiety, depression and posttraumatic stress disorder.
Fundamental findings
This basic research into hard-to-tackle medical problems is precisely the mission of the FMI. “When the institute was created in 1970 its initial goal was to provide Ciba and Geigy with new ways to drive innovation by tapping into basic research and translate this knowledge into viable products,” says Novartis Chairman Joerg Reinhardt. “The FMI has proven that it is able to bridge the traditional divide between industry and academia.”
Reinhardt goes on that the FMI has done much more than that: “The institute has been successful in setting up new forms of scientific collaboration and has built a unique educational platform, which gives promising scientists the opportunity to deepen their basic research skills while at the same time learning more about the pharmaceutical industry – adding strength to both.”
Collaboration with NIBR is key for the FMI – over 400 collaborations between FMI and Novartis researchers have been put in place since 1998. On the other hand, the FMI is also well established in the academic landscape. The FMI is an affiliated institute of the University of Basel where most of today’s group leaders hold professorships and teach, while they are also engaged in intensive collaboration with faculties around the globe in the realms of neurobiology, epigenetics and quantitative biology.
By seeking collaboration with pan-European science initiatives, such as EU-Life and LifeTime, the FMI has created a strong knowledge network. FMI scientists regularly publish their results in the most renowned scientific journals and they have been extremely successful in attracting competitive third-party funding, such as prestigious ERC grants. All this helps to attract some of the most talented young scientists in the world.
The fact that the institute is home to over 80 postdocs and over 80 Ph.D. students from more than 40 countries speaks impressively of its international attractiveness as a center of excellence for top-notch researchers, including in brain and memory research.